CRISPR Therapeutics AG (CRSP): Shares Outstanding
95.89M
As of 2025-12-31
96.66M
As of 2026-06-30
+6.9%
3-year compound annual growth
+5.3%
5-year compound annual growth
+33.0%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 95.89M | +11.8% | 2026-02-12, Balance as of period end |
| 2024-12-31 | 85.74M | +7.1% | 2026-02-12, Balance as of period end |
| 2023-12-31 | 80.04M | +2.0% | 2025-02-11, Balance as of period end |
| 2022-12-31 | 78.51M | +2.0% | 2024-02-21, Balance as of period end |
| 2021-12-31 | 76.99M | +4.2% | 2023-02-21, Balance as of period end |
| 2020-12-31 | 73.91M | +21.6% | 2022-02-15, Balance as of period end |
| 2019-12-31 | 60.78M | +17.2% | 2021-02-16, Balance as of period end |
| 2018-12-31 | 51.85M | +27.7% | 2020-02-12, Balance as of period end |
| 2017-12-31 | 40.59M | +2.2% | 2019-02-25, Balance as of period end |
| 2016-12-31 | 39.72M | +618.5% | 2018-03-08, Balance as of period end |
| 2015-12-31 | 5.53M | n/a | 2017-03-10, Balance as of period end |